BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,444,000 | +65.6% | 9,552 | +29.9% | 0.04% | +80.0% |
Q1 2022 | $872,000 | -76.9% | 7,356 | -73.0% | 0.02% | -80.8% |
Q3 2021 | $3,778,000 | +793.1% | 27,200 | +168.2% | 0.10% | +166.7% |
Q3 2019 | $423,000 | -50.1% | 10,142 | -47.6% | 0.04% | -49.4% |
Q2 2019 | $848,000 | +53.9% | 19,360 | +32.0% | 0.08% | +42.6% |
Q3 2018 | $551,000 | +88.1% | 14,665 | +29.1% | 0.05% | +54.3% |
Q1 2018 | $293,000 | – | 11,358 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |